Salvia miltiorrhiza Roots against Cardiovascular Disease: Consideration of Herb-Drug Interactions

Feng Chen, Li Li, Dan-Dan Tian, Feng Chen, Li Li, Dan-Dan Tian

Abstract

Salvia miltiorrhiza root (Danshen) is widely used in Asia for its cardiovascular benefits and contains both hydrophilic phenolic acids and lipophilic tanshinones, which are believed to be responsible for its therapeutic efficacy. This review summarized the effects of these bioactive components from S. miltiorrhiza roots on pharmacokinetics of comedicated drugs with mechanic insights regarding alterations of protein binding, enzyme activity, and transporter activity based on the published data stemming from both in vitro and in vivo human studies. In vitro studies indicated that cytochrome P450 (CYP450), carboxylesterase enzyme, catechol-O-methyltransferase, organic anion transporter 1 (OAT1) and OAT3, and P-glycoprotein were the major targets involved in S. miltiorrhiza-drug interactions. Lipophilic tanshinones had much more potent inhibitory effects towards CYPs activities compared to hydrophilic phenolic acids, evidenced by much lower Ki values of the former. Clinical S. miltiorrhiza-drug interaction studies were mainly conducted using CYP1A2 and CYP3A4 probe substrates. In addition, the effects of coexisting components on the pharmacokinetic behaviors of those noted bioactive compounds were also included herein.

Figures

Figure 1
Figure 1
Structures of major constituents from Danshen.

References

    1. World Health Organization. Cardiovascular Diseases (CVDs) 2014.
    1. Peters J.-U. Polypharmacology—foe or friend? Journal of Medicinal Chemistry. 2013;56(22):8955–8971. doi: 10.1021/jm400856t.
    1. World Health Organization. Traditional Medicine. 2008. .
    1. Grant S. J., Bin Y. S., Kiat H., Chang D. H.-T. The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review. BMC Public Health. 2012;12, article 299 doi: 10.1186/1471-2458-12-299.
    1. Brantley S. J., Argikar A. A., Lin Y. S., Nagar S., Paine M. F. Herb-drug interactions: challenges and opportunities for improved predictions. Drug Metabolism and Disposition. 2014;42(3):301–317. doi: 10.1124/dmd.113.055236.
    1. Lu W. I., Lu D. P. Impact of chinese herbal medicine on american society and health care system: perspective and concern. Evidence-based Complementary and Alternative Medicine. 2014;2014 doi: 10.1155/2014/251891.251891
    1. Tian D.-D., Jia W.-W., Liu X.-W., et al. Methylation and its role in the disposition of tanshinol, a cardiovascular carboxylic catechol from Salvia miltiorrhiza roots (Danshen) Acta Pharmacologica Sinica. 2015;36(5):627–643. doi: 10.1038/aps.2015.20.
    1. Ji X.-Y., Tan B. K.-H., Zhu Y.-Z. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacologica Sinica. 2000;21(12):1089–1094.
    1. Jia Y., Huang F., Zhang S., Leung S.-W. Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials. International Journal of Cardiology. 2012;157(3):330–340. doi: 10.1016/j.ijcard.2010.12.073.
    1. Ma B.-L., Ma Y.-M. Pharmacokinetic herb-drug interactions with traditional Chinese medicine: progress, causes of conflicting results and suggestions for future research. Drug Metabolism Reviews. 2016;48(1):1–26. doi: 10.3109/03602532.2015.1124888.
    1. Tian D. D., Hu Z. Y. CYP3A4-mediated pharmacokinetic interactions in cancer therapy. Current Drug Metabolism. 2014;15(8):808–817. doi: 10.2174/1389200216666150223152627.
    1. Zhao Y.-S., Chen F., Li L. Are circulating metabolites important in pharmacokinetic drug-drug interactions? A retroanalysis of clinical data. Current Drug Metabolism. 2014;15(8):767–790. doi: 10.2174/1389200216666150223152113.
    1. Su C.-Y., Ming Q.-L., Rahman K., Han T., Qin L.-P. Salvia miltiorrhiza: traditional medicinal uses, chemistry, and pharmacology. Chinese Journal of Natural Medicines. 2015;13(3):163–182. doi: 10.1016/s1875-5364(15)30002-9.
    1. Hochman J., Tang C., Prueksaritanont T. Drug-drug interactions related to altered absorption and plasma protein binding: theoretical and regulatory considerations, and an industry perspective. Journal of Pharmaceutical Sciences. 2015;104(3):916–929. doi: 10.1002/jps.24306.
    1. Liu X., Wright M., Hop C. E. C. A. Rational use of plasma protein and tissue binding data in drug design. Journal of Medicinal Chemistry. 2014;57(20):8238–8248. doi: 10.1021/jm5007935.
    1. Schmidt S., Gonzalez D., Derendorf H. Significance of protein binding in pharmacokinetics and pharmacodynamics. Journal of Pharmaceutical Sciences. 2010;99(3):1107–1122. doi: 10.1002/jps.21916.
    1. Musteata F. M. Monitoring free drug concentrations: challenges. Bioanalysis. 2011;3(15):1753–1768. doi: 10.4155/bio.11.187.
    1. Persky A. M., Pollack G. M. Foundations in Pharmacokinetics (Enhanced Edition) Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; 2017.
    1. Peng X., Qi W., Huang R., Su R., He Z. Elucidating the influence of gold nanoparticles on the binding of salvianolic acid B and rosmarinic acid to bovine serum albumin. PLoS ONE. 2015;10(4) doi: 10.1371/journal.pone.0118274.e0118274
    1. Shao X., Ai N., Xu D., Fan X. Exploring the interaction between Salvia miltiorrhiza and human serum albumin: insights from herb-drug interaction reports, computational analysis and experimental studies. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2016;161:1–7. doi: 10.1016/j.saa.2016.02.015.
    1. Chen T., Cao H., Zhu S., et al. Investigation of the binding of Salvianolic acid B to human serum albumin and the effect of metal ions on the binding. Spectrochimica Acta—Part A: Molecular and Biomolecular Spectroscopy. 2011;81(1):645–652. doi: 10.1016/j.saa.2011.06.068.
    1. Peng X., Wang X., Qi W., Su R., He Z. Affinity of rosmarinic acid to human serum albumin and its effect on protein conformation stability. Food Chemistry. 2016;192:178–187. doi: 10.1016/j.foodchem.2015.06.109.
    1. Li J. H., Wang S. M. Application of molecular modelling and spectroscopic approaches for investigating the binding of tanshinone IIA to human serum albumin. The Journal of Chemical Thermodynamics. 2013;58:206–210. doi: 10.1016/j.jct.2012.11.009.
    1. Chen D., Tu X., Zhang Y. Determination of plasma protein binding rate of salvianol acid a by ultrafiltration. Yao Xue Xue Bao. 2012;2
    1. Wu Y.-T., Chen Y.-F., Hsieh Y.-J., Jaw I., Shiao M.-S., Tsai T.-H. Bioavailability of salvianolic acid B in conscious and freely moving rats. International Journal of Pharmaceutics. 2006;326(1-2):25–31. doi: 10.1016/j.ijpharm.2006.07.003.
    1. Jing C.-J., Chen X.-H., Liu X., Bi K.-S., Guo D.-A. Determination of the binding rate of rat plasma protein with salvianolic acid B. Yaoxue Xuebao. 2010;45(3):343–346.
    1. Hao H., Wang G., Cui N., Li J., Xie L., Ding Z. Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion. Planta Medica. 2006;72(14):1311–1317. doi: 10.1055/s-2006-951698.
    1. Liu J., Wang X., Cai Z., Lee F. S. C. Effect of tanshinone IIA on the noncovalent interaction between warfarin and human serum albumin studied by electrospray ionization mass spectrometry. Journal of the American Society for Mass Spectrometry. 2008;19(10):1568–1575. doi: 10.1016/j.jasms.2008.06.005.
    1. Zhang Z., Ge B., Zhou L., Lam T.-N., Zuo Z. Induction of liver cytochrome P450s by Danshen-Gegen formula is the leading cause for its pharmacokinetic interactions with warfarin. Journal of Ethnopharmacology. 2014;154(3):672–686. doi: 10.1016/j.jep.2014.04.047.
    1. Gupta D., Jalali M., Wells A., Dasgupta A. Drug-herb interactions: unexpected suppression of free Danshen concentrations by salicylate. Journal of Clinical Laboratory Analysis. 2002;16(6):290–294. doi: 10.1002/jcla.10057.
    1. Chen D., Lin X.-X., Huang W.-H., et al. Sodium tanshinone IIA sulfonate and its interactions with human CYP450s. Xenobiotica. 2016;46(12):1085–1092. doi: 10.3109/00498254.2016.1152417.
    1. Qin C.-Z., Ren X., Zhou H.-H., Mao X.-Y., Liu Z.-Q. Inhibitory effect of salvianolate on human cytochrome P450 3A4 in vitro involving a noncompetitive manner. International Journal of Clinical and Experimental Medicine. 2015;8(9):15549–15555.
    1. Qiu F., Jiang J., Ma Y., et al. Opposite effects of single-dose and multidose administration of the ethanol extract of danshen on CYP3A in healthy volunteers. Evidence-Based Complementary and Alternative Medicine. 2013;2013 doi: 10.1155/2013/730734.730734
    1. Wang X., Yeung J. H.-K. Investigation of cytochrome P450 1A2 and 3A inhibitory properties of Danshen tincture. Phytomedicine. 2012;19(3-4):348–354. doi: 10.1016/j.phymed.2011.09.075.
    1. Wang X., Yeung J. H. K. Effects of Salvia miltiorrhiza extract on the liver CYP3A activity in humans and rats. Phytotherapy Research. 2011;25(11):1653–1659. doi: 10.1002/ptr.3472.
    1. Wang X., Cheung C. M., Lee W. Y. W., Or P. M. Y., Yeung J. H. K. Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro. Phytomedicine. 2010;17(11):868–875. doi: 10.1016/j.phymed.2010.05.003.
    1. Qiu F., Zhang R., Sun J., et al. Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes. Drug Metabolism & Disposition. 2008;36(7):1308–1314. doi: 10.1124/dmd.108.021030.
    1. He F., Bi H.-C., Xie Z.-Y., et al. Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high-throughput inhibition screening of terpenoids. Rapid Communications in Mass Spectrometry. 2007;21(5):635–643. doi: 10.1002/rcm.2881.
    1. Ueng Y.-F., Kuo Y.-H., Peng H.-C., et al. Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome P4501A2. Xenobiotica. 2003;33(6):603–613. doi: 10.1080/0049825031000105769.
    1. Wang Q.-L., Wu Q., Tao Y.-Y., Liu C.-H., El-Nezami H. Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells. Hepatobiliary and Pancreatic Diseases International. 2011;10(5):502–508. doi: 10.1016/S1499-3872(11)60085-4.
    1. Zhou X., Chan K., Yeung J. H. K. Herb-drug interactions with Danshen (Salvia miltiorrhiza): a review on the role of cytochrome P450 enzymes. Drug Metabolism and Drug Interactions. 2012;27(1):9–18. doi: 10.1515/dmdi-2011-0038.
    1. Yu C., Ye S., Sun H., et al. PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA. Chemico-Biological Interactions. 2009;177(1):58–64. doi: 10.1016/j.cbi.2008.08.013.
    1. Zhang R., Sun J., Ma L., et al. Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line. Toxicology and Applied Pharmacology. 2011;252(1):18–27. doi: 10.1016/j.taap.2011.01.008.
    1. Hatfield M. J., Tsurkan L. G., Hyatt J. L., et al. Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza (“Danshen”) Journal of Natural Products. 2013;76(1):36–44. doi: 10.1021/np300628a.
    1. Lu T., Yang J., Gao X., et al. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine. Drug Metabolism and Disposition. 2008;36(8):1578–1586. doi: 10.1124/dmd.108.021592.
    1. Zhang Y., Akao T., Nakamura N., et al. Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza, in rat. Planta Medica. 2004;70(2):138–142. doi: 10.1055/s-2004-815490.
    1. Wang L., Zhang Q., Li X., et al. Pharmacokinetics and metabolism of lithospermic acid by LC/MS/MS in rats. International Journal of Pharmaceutics. 2008;350(1-2):240–246. doi: 10.1016/j.ijpharm.2007.09.001.
    1. Zhang Y., Jiang P., Ye M., Kim S.-H., Jiang C., Lü J. Tanshinones: sources, pharmacokinetics and anti-cancer activities. International Journal of Molecular Sciences. 2012;13(10):13621–13666. doi: 10.3390/ijms131013621.
    1. Zhang J., Huang M., Guan S., et al. A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza. Journal of Pharmacology and Experimental Therapeutics. 2006;317(3):1285–1294. doi: 10.1124/jpet.105.100701.
    1. Paine M. F., Oberlies N. H. Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactions. Expert Opinion on Drug Metabolism and Toxicology. 2007;3(1):67–80. doi: 10.1517/17425255.3.1.67.
    1. Giacomini K. M., Huang S.-M., Tweedie D. J., et al. Membrane transporters in drug development. Nature Reviews Drug Discovery. 2010;9(3):215–236. doi: 10.1038/nrd3028.
    1. König J., Müller F., Fromm M. F. Transporters and drug-drug interactions: important determinants of drug disposition and effects. Pharmacological Reviews. 2013;65(3):944–966. doi: 10.1124/pr.113.007518.
    1. Wu X., Ma J., Ye Y., Lin G. Transporter modulation by Chinese herbal medicines and its mediated pharmacokinetic herb–drug interactions. Journal of Chromatography B. 2016;1026:236–253. doi: 10.1016/j.jchromb.2015.11.024.
    1. Wang L., Sweet D. H. Competitive inhibition of human organic anion transporters 1 (SLC22A6), 3 (SLC22A8) and 4 (SLC22A11) by major components of the medicinal herb Salvia miltiorrhiza (Danshen) Drug Metabolism and Pharmacokinetics. 2013;28(3):220–228. doi: 10.2133/dmpk.dmpk-12-rg-116.
    1. Wang L., Sweet D. H. Potential for food-drug interactions by dietary phenolic acids on human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11) Biochemical Pharmacology. 2012;84(8):1088–1095. doi: 10.1016/j.bcp.2012.07.027.
    1. Jia W., Du F., Liu X., et al. Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions. Drug Metabolism and Disposition. 2015;43(5):669–678. doi: 10.1124/dmd.114.062000.
    1. Cai J., Chen S., Zhang W., et al. Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway. Phytomedicine. 2014;21(12):1725–1732. doi: 10.1016/j.phymed.2014.08.007.
    1. Zhang J.-L., Cui M., He Y., Yu H.-L., Guo D.-A. Chemical fingerprint and metabolic fingerprint analysis of Danshen injection by HPLC-UV and HPLC-MS methods. Journal of Pharmaceutical and Biomedical Analysis. 2005;36(5):1029–1035. doi: 10.1016/j.jpba.2004.09.009.
    1. Hu T., To K. K. W., Wang L., et al. Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza. Phytomedicine. 2014;21(11):1264–1272. doi: 10.1016/j.phymed.2014.06.013.
    1. Li X.-X., Zhou Z.-W., Zhou S.-F. Role of P-glycoprotein in the transport of tanshinone I, one active triterpenoid from Salvia miltiorrhiza. Drug Metabolism Letters. 2008;2(3):223–230. doi: 10.2174/187231208785425746.
    1. Yu X.-Y., Lin S.-G., Zhou Z.-W., et al. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge. Current Drug Metabolism. 2007;8(4):325–340. doi: 10.2174/138920007780655450.
    1. Qiu F., Zeng J., Liu S., et al. Effects of danshen ethanol extract on the pharmacokinetics of fexofenadine in healthy volunteers. Evidence-Based Complementary and Alternative Medicine. 2014;2014 doi: 10.1155/2014/473213.473213
    1. Yin Y., Yang M., Wang Y., et al. Tanshinone IIA increases mRNA expression of efflux transporters in cultured human intestinal cell. The American Journal of Chinese Medicine. 2010;38(5):995–1004. doi: 10.1142/s0192415x1000841x.
    1. Wang X., Yeung J. H. K. Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats. Journal of Pharmacy and Pharmacology. 2010;62(8):1077–1083. doi: 10.1111/j.2042-7158.2010.01127.x.
    1. Qiu F., Wang G., Zhao Y., et al. Effect of danshen extract on pharmacokinetics of theophylline in healthy volunteers. British Journal of Clinical Pharmacology. 2008;65(2):270–274.
    1. Chen Y., Tu J.-H., He Y.-J., et al. Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers. Xenobiotica. 2009;39(7):508–513. doi: 10.1080/00498250902951763.
    1. Qiu F., Wang G., Zhang R., Sun J., Jiang J., Ma Y. Effect of danshen extract on the activity of CYP3A4 in healthy volunteers. British Journal of Clinical Pharmacology. 2010;69(6):656–662. doi: 10.1111/j.1365-2125.2010.03624.x.
    1. Wang P., Sun H., Yang L., et al. Absence of an effect of T89 on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers. The Journal of Clinical Pharmacology. 2014;54(2):234–239. doi: 10.1002/jcph.209.
    1. Kuo Y.-H., Lin Y.-L., Don M.-J., Chen R.-M., Ueng Y.-F. Induction of cytochrome P450-dependent monooxygenase by extracts of the medicinal herb Salvia miltiorrhiza. Journal of Pharmacy and Pharmacology. 2006;58(4):521–527. doi: 10.1211/jpp.58.4.0012.
    1. Qin W., Wang B., Lu X., Liu H., Wang L., Qi W. Determination of Sodium Tanshinone IIA Sulfonate in human plasma by LC-MS/MS and its application to a clinical pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 2016;121:204–208. doi: 10.1016/j.jpba.2016.01.026.
    1. Kaminsky L. S., Zhang Z.-Y. Human P450 metabolism of warfarin. Pharmacology and Therapeutics. 1997;73(1):67–74. doi: 10.1016/S0163-7258(96)00140-4.
    1. Tam L. S., Chan T. Y. K., Leung W. K., Critchley J. A. J. H. Warfarin interactions with Chinese traditional medicines: danshen and methyl salicylate medicated oil. Australian and New Zealand Journal of Medicine. 1995;25(3):p. 258. doi: 10.1111/j.1445-5994.1995.tb01540.x.
    1. Yu C. M., Chan J. C. N., Sanderson J. E. Chinese herbs and warfarin potentiation by ‘danshen’. Journal of Internal Medicine. 1997;241(4):337–339. doi: 10.1046/j.1365-2796.1997.134137000.x.
    1. Izzat M. B., Yim A. P. C., El-Zufari M. H. A taste of chinese medicine! Annals of Thoracic Surgery. 1998;66(3):941–942. doi: 10.1016/S0003-4975(98)00624-9.
    1. Yan Q., Jiang J. Q. Effect of Danshen tablet on anticogulation of warfarin. Chinese Traditional Patent Medicine. 2008;30(1):19–21.
    1. Chang B.-B., Zhang L., Cao W.-W., et al. Pharmacokinetic interactions induced by content variation of major water-soluble components of Danshen preparation in rats. Acta Pharmacologica Sinica. 2010;31(5):638–646. doi: 10.1038/aps.2010.27.
    1. Guo Z.-J., Zhang Y., Tang X., Li H., Sun Q.-S. Pharmacokinetic interaction between tanshinones and polyphenolic extracts of Salvia miltinorrhiza Bunge after intravenous administration in rats. Biological and Pharmaceutical Bulletin. 2008;31(8):1469–1474. doi: 10.1248/bpb.31.1469.
    1. Song M., Hang T.-J., Zhang Z., Chen H.-Y. Effects of the coexisting diterpenoid tanshinones on the pharmacokinetics of cryptotanshinone and tanshinone IIA in rat. European Journal of Pharmaceutical Sciences. 2007;32(4-5):247–253. doi: 10.1016/j.ejps.2007.07.007.
    1. Dai H., Li X., Li X., Bai L., Li Y., Xue M. Coexisted components of Salvia miltiorrhiza enhance intestinal absorption of cryptotanshinone via inhibition of the intestinal P-gp. Phytomedicine. 2012;19(14):1256–1262. doi: 10.1016/j.phymed.2012.08.007.
    1. Huang J., Zhang J., Bai J., Xu W., Wu D., Qiu X. LC-MS/MS determination and interaction of the main components from the traditional Chinese drug pair Danshen-Sanqi based on rat intestinal absorption. Biomedical Chromatography. 2016;30(12):1928–1934. doi: 10.1002/bmc.3768.
    1. Yang S., Zhang K., Lin X., et al. Pharmacokinetic comparisons of single herb extract of Fufang Danshen preparation with different combinations of its constituent herbs in rats. Journal of Pharmaceutical and Biomedical Analysis. 2012;67-68:77–85. doi: 10.1016/j.jpba.2012.03.058.
    1. Long W., Zhang S.-C., Wen L., Mu L., Yang F., Chen G. In vivo distribution and pharmacokinetics of multiple active components from Danshen and Sanqi and their combination via inner ear administration. Journal of Ethnopharmacology. 2014;156:199–208. doi: 10.1016/j.jep.2014.08.041.
    1. Zhou L., Chow M. S. S., Zuo Z. Effect of sodium caprate on the oral absorptions of danshensu and salvianolic acid B. International Journal of Pharmaceutics. 2009;379(1-2):109–118. doi: 10.1016/j.ijpharm.2009.06.016.
    1. Zhao D., Gao Z.-D., Han D.-E., et al. Influence of rifampicin on the pharmacokinetics of salvianolic acid B may involve inhibition of organic anion transporting polypeptide (Oatp) mediated influx. Phytotherapy Research. 2012;26(1):118–121. doi: 10.1002/ptr.3522.
    1. Li M., Wang F., Huang Y., et al. Systemic exposure to and disposition of catechols derived from Salvia miltiorrhiza roots (Danshen) after intravenous dosing danhong injection in human subjects, rats, and dogs. Drug Metabolism and Disposition. 2015;43(5):679–690. doi: 10.1124/dmd.114.061473.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅